BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

480 related articles for article (PubMed ID: 17085104)

  • 1. The application of botulinum toxin in the prostate.
    Chuang YC; Chancellor MB
    J Urol; 2006 Dec; 176(6 Pt 1):2375-82. PubMed ID: 17085104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum-A toxin: an exciting new treatment option for prostatic disease.
    Thomas CA; Guercini F; Chuang YC; Chancellor MB
    Int J Clin Pract Suppl; 2006 Dec; (151):33-7. PubMed ID: 17169009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The potential and promise of using botulinum toxin in the prostate gland.
    Chuang YC; Giannantoni A; Chancellor MB
    BJU Int; 2006 Jul; 98(1):28-32. PubMed ID: 16831138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urodynamic effects of transrectal intraprostatic Ona botulinum toxin A injections for symptomatic benign prostatic hyperplasia.
    de Kort LM; Kok ET; Jonges TN; Rosier PF; Bosch JL
    Urology; 2012 Oct; 80(4):889-93. PubMed ID: 22854138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is botulinum neurotoxin type A (BoNT-A) a novel therapy for lower urinary tract symptoms due to benign prostatic enlargement? A review of the literature.
    Oeconomou A; Madersbacher H; Kiss G; Berger TJ; Melekos M; Rehder P
    Eur Urol; 2008 Oct; 54(4):765-75. PubMed ID: 18571306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum toxin for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia.
    Antunes AA; Srougi M; Coelho RF; de Campos Freire G
    Nat Clin Pract Urol; 2007 Mar; 4(3):155-60. PubMed ID: 17347660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relief by botulinum toxin of lower urinary tract symptoms owing to benign prostatic hyperplasia: early and long-term results.
    Brisinda G; Cadeddu F; Vanella S; Mazzeo P; Marniga G; Maria G
    Urology; 2009 Jan; 73(1):90-4. PubMed ID: 18995889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perspective of Botox for treatment of male lower urinary tract symptoms.
    Ilie CP; Chancellor MB
    Curr Opin Urol; 2009 Jan; 19(1):20-5. PubMed ID: 19057212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Injection of botulinum toxin type A in the urethral sphincter to treat lower urinary tract dysfunction: a review of indications, techniques and results.
    Karsenty G; Baazeem A; Elzayat E; Corcos J
    Can J Urol; 2006 Apr; 13(2):3027-33. PubMed ID: 16672114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate botulinum A toxin injection--an alternative treatment for benign prostatic obstruction in poor surgical candidates.
    Kuo HC
    Urology; 2005 Apr; 65(4):670-4. PubMed ID: 15833506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum neurotoxin A for benign prostatic hyperplasia.
    Oeconomou A; Madersbacher H
    Curr Opin Urol; 2010 Jan; 20(1):28-36. PubMed ID: 19887944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraprostatic botulinum toxin a injection inhibits cyclooxygenase-2 expression and suppresses prostatic pain on capsaicin induced prostatitis model in rat.
    Chuang YC; Yoshimura N; Huang CC; Wu M; Chiang PH; Chancellor MB
    J Urol; 2008 Aug; 180(2):742-8. PubMed ID: 18554636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of botulinum toxin A injection for the management of external sphincter dyssynergia in neurologically normal children.
    Franco I; Landau-Dyer L; Isom-Batz G; Collett T; Reda EF
    J Urol; 2007 Oct; 178(4 Pt 2):1775-9; discussion 1779-80. PubMed ID: 17707430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin: a new dimension in the treatment of lower urinary tract dysfunction.
    Rajkumar GN; Conn IG
    Urology; 2004 Jul; 64(1):2-8. PubMed ID: 15245922
    [No Abstract]   [Full Text] [Related]  

  • 15. Prostatic tissue ablation by injection: a literature review.
    Plante MK; Folsom JB; Zvara P
    J Urol; 2004 Jul; 172(1):20-6. PubMed ID: 15201730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The case for bladder botulinum toxin application.
    Kim DK; Thomas CA; Smith C; Chancellor MB
    Urol Clin North Am; 2006 Nov; 33(4):503-10, ix. PubMed ID: 17011386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum toxin injection therapy in the management of lower urinary tract dysfunction.
    Patel AK; Chapple CR
    Int J Clin Pract Suppl; 2006 Dec; (151):1-7. PubMed ID: 17169004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum toxin for the treatment of lower urinary tract symptoms: a review.
    Sahai A; Khan M; Fowler CJ; Dasgupta P
    Neurourol Urodyn; 2005; 24(1):2-12. PubMed ID: 15578628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigating botulinum toxin A on the functional properties of the prostate.
    Choo MS
    Eur Urol; 2007 Aug; 52(2):324-5. PubMed ID: 17376584
    [No Abstract]   [Full Text] [Related]  

  • 20. Botulinum toxin for detrusor overactivity and symptoms of overactive bladder: where we are now and where we are going.
    Sahai A; Khan MS; Gregson N; Smith K; Dasgupta P;
    Nat Clin Pract Urol; 2007 Jul; 4(7):379-86. PubMed ID: 17615549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.